fda semaglutide compounding enforcement november 2025 Novo Nordisk expands legal action to protect US patients from unsafe, non- FDA-approved compounded "semaglutide" Hims & Hers launched a

As of February 2026, Eli Lilly plans to submit orforglipron for FDA approval as a diabetes treatment sometime in 2026

Some patients may benefit from dietary changes or oral supplements, while others may require injections to restore healthy vitamin B12 levels more effectively

Its also not ideal for people who want a fully specialized program

Instead, the Tufts team was able to join two peptide segments end-to-end, creating a new tetra-functional clinical candidate

Conversely, diarrhoea affects a similar proportion of users, possibly due to altered fluid secretion and absorption in the intestines

Is coverage provided at 100%, or is there member cost-sharing (e.g., 50%)